QNCX (Quince Therapeutics, Inc. Common Stock) Stock Analysis - Politician Trades

Quince Therapeutics, Inc. Common Stock (QNCX) is a publicly traded Healthcare sector company. As of May 21, 2026, QNCX trades at $1.04 with a market cap of $16.22M and a P/E ratio of -0.64. QNCX moved +0.00% today. Year to date, QNCX is -96.22%; over the trailing twelve months it is -89.41%. Its 52-week range spans $0.79 to $45.50. Rallies surfaces QNCX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded QNCX stock?

Rallies tracks politician and congressional stock disclosures for QNCX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

QNCX Key Metrics

Key financial metrics for QNCX
MetricValue
Price$1.04
Market Cap$16.22M
P/E Ratio-0.64
EPS$-1.68
Dividend Yield0.00%
52-Week High$45.50
52-Week Low$0.79
Volume97.21K
Avg Volume0
Revenue (TTM)$0
Net Income$-80.77M
Gross Margin0.00%

Latest QNCX News

Recent QNCX Insider Trades

  • Benatti Luca sold 50.00K (~$173.50K) on Dec 26, 2025.
  • Thye Dirk bought 77.00K (~$53.90K) on Aug 30, 2024.
  • Thye Dirk bought 77.50K (~$53.47K) on Aug 29, 2024.

QNCX Analyst Consensus

QNCX analyst coverage data. Average price target: $0.00.

Common questions about QNCX

Which politicians traded QNCX stock?
Rallies tracks politician and congressional stock disclosures for QNCX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in QNCX?
Yes. Rallies tracks politician and congressional stock disclosures for QNCX, including reported purchases, sales, dates, owners, and trade amounts when available.
Is QNCX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for QNCX. It does not provide personalized investment advice.
QNCX

QNCX